RO-10-5824 is a selective dopamine D4 receptor agonist that increases novel object exploration in C57 mice

Neuropharmacology

Volumn 44, Issue 4, 2003, Pages 473-481

  Powell, Susan B ^a   Paulus, Martin P ^a   Hartman, Deborah S ^b,c   Godel, Thierry ^b   Geyer, Mark A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c ASTRAZENECA   (United Kingdom)

Author keywords

Approach avoidance; D4 agonist; Locomotion; Novelty seeking; Open field; Strain differences

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; RO 10 5824; RO 105824; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; EXPLORATORY BEHAVIOR; GENETIC DIFFERENCE; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; OBJECT RELATION; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; RECEPTOR AFFINITY;

EID: 0037333504     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(02)00412-4     Document Type: Article

References (48)

1. Ariano M.A., Wang J., Noblett K.L., Larson E.R., Sibley D.R. Cellular distribution of the rat D4 dopamine receptor protein in the CNS using anti-receptor antisera. Brain Research. 752:1997;26-34.
2. Asghari V., Schoots O., van Kats S., Ohara K., Jovanovic V., Guan H.C., Bunzow J.R., Petronis A., Van Tol H.H. Dopamine D4 receptor repeat: analysis of different native and mutant forms of the human and rat genes. Mol Pharmacol. 46:1994;364-373.
3. Beesheer J., Bevins R.A. The role of environmental familiarization in novel-object preference. Behav Process. 50:2000;19-29.
4. Beesher J., Short K.R., Bevins R.A. Dopaminergic and cholinergic antagonism in a novel-object detection task with rats. Behav Brain Res. 126:2001;211-217.
5. Benjamin J., Li L., Patterson C., Greenberg B.D., Murphy D.L., Hamer D.H. Population and familial association between the D4 dopamine receptor gene and measures of Novelty Seeking. Nat Genet. 12:1996;81-84.
6. Berlyne D.E. Conflict, Arousal, and Curiosity. 1960;McGraw-Hill Book Co, New York.
7. Clifford J.J., Waddington J.L. Topographically based search for an 'Ethogram' among a series of novel D(4) dopamine receptor agonists and antagonists. Neuropsychopharmacology. 22:2000;538-544.
8. Cloninger C.R. A systematic method for clinical description and classification of personality variants. A proposal. Arch Gen Psychiatry. 44:1987;573-588.
9. Crabbe J.C., Belknap J.K. Genetic approaches to drug dependence. Trends Pharmacol Sci. 13:1992;212-219.
10. Dellu F., Contarino A., Simon H., Koob G.F., Gold L.H. Genetic differences in response to novelty and spatial memory using a two-trial recognition task in mice. Neurobiol Learn Mem. 73:2000;31-48.
11. Dulawa S.C., Grandy D.K., Low M.J., Paulus M.P., Geyer M.A. Dopamine D4 receptor knock-out mice exhibit reduced exploration of novel stimuli. J Neurosci. 19:1999;9550-9556.
12. Ebstein R.P., Novick O., Umansky R., Priel B., Osher Y., Blaine D., Bennett E.R., Nemanov L., Katz M., Belmaker R.H. Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking. Nat Genet. 12:1996;78-80.
13. Elias P.K., Elias M.F., Eleftheriou B.E. Emotionality, exploratory behavior, and locomotion in aging inbred strains of mice. Gerontologia. 21:1975;46-55.
14. Ennaceur A., Delacour J. A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data. Behav Brain Res. 31:1988;47-59.
15. Faraone S.V., Doyle A.E., Mick E., Biederman J. Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. Am J Psychiatry. 158:2001;1052-1057.
16. Flicker C., Geyer M.A. Behavior during hippocampal microinfusions. I. Norepinephrine and diversive exploration. Brain Res. 257:1982;79-103.
17. Gazi L., Schoeffer P., Nunn C., Croskery K., Hoyer D., Feuerbach D. Cloning, expression, functional coupling and pharmacological characterization of the rat dopamine D4 receptor. Naunyn-Schmiedeberg's Arch Pharmacol. 361:2000;555-564.
18. Godel, T., Reimer, C., Edenhofer, A., 1997. PCT Int. Appl. WO 9713759.
19. Jonsson E.G., Ivo R., Gustavsson J.P., Geijer T., Forslund K., Mattila-Evenden M., Rylander G., Cichon S., Propping P., Bergman H., Sberg M., Nothen M.M. No association between dopamine D4 receptor gene variants and novelty seeking. Mol Psychiatry. 7:2002;18-20.
20. Kabbaj M., Devine D.P., Savage V.R., Akil H. Neurobiological correlates of individual differences in novelty-seeking behavior in the rat: differential expression of stress-related molecules. J Neurosci. 20:2000;6983-6988.
21. Klebaur J.E., Bardo M.T. Individual differences in novelty seeking on the playground maze predict amphetamine conditioned place preference. Pharmacol Biochem Behav. 63:1999;131-136.
22. Kosten T.A., Ball S.A., Rounsaville B.J. A sibling study of sensation seeking and opiate addiction. J Nerv Ment Dis. 182:1994;284-289.
23. Kotler M., Cohen H., Segman R., Gritsenko I., Nemanov L., Lerer B., Kramer I., Zer-Zion M., Kletz I., Ebstein R.P. Excess dopamine D4 receptor (D4DR) exon III seven repeat allele in opioid-dependent subjects. Mol Psychiatry. 2:1997;251-254.
24. Kuhn K.U., Meyer K., Nothen M.M., Gansicke M., Papassotiropoulos A., Maier W. Allelic variants of dopamine receptor D4 (DRD4) and serotonin receptor 5HT2c (HTR2c) and temperament factors: replication tests. Am J Med Genet. 88:1999;168-172.
25. Lanau F., Brockhaus M., Pink J.R., Franchet C., Wildt-Perinic D., Goepfert C., Probst A., Hartman D.S. Development and characterization of antibodies against the N terminus of the human dopamine D4 receptor. J Neurochem. 69:1997a;2169-2178.
26. Lanau F., Zenner M.T., Civelli O., Hartman D.S. Epinephrine and norepinephrine act as potent agonists at the recombinant human dopamine D4 receptor. J Neurochem. 68:1997b;804-812.
27. Lichter J.B., Barr C.L., Kennedy J.L., Van Tol H.H., Kidd K.K., Livak K.J. A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. Hum Mol Genet. 2:1993;767-773.
28. Mitsuyasu H., Hirata N., Sakai Y., Shibata H., Takeda Y., Ninomiya H., Kawasaki H., Tashiro N., Fukumaki Y. Association analysis of polymorphisms in the upstream region of the human dopamine D4 receptor gene (DRD4) with schizophrenia and personality traits. J Hum Genet. 46:2001;26-31.
29. Montgomery K.C. The relation between fear induced by novel stimulation and exploratory drive. J Comp Phys Psychol. 48:1955;254-260.
30. Mrzljak L., Bergson C., Pappy M., Huff R., Levenson R., Goldman-Rakic P.S. Localization of dopamine D4 receptors in GABAergic neurons of the primate brain. Nature. 381:1996;245-248.
31. Newman-Tancredi A., Audinot-Bouchez V., Gobert A., Millan M.J. Noradrenaline and adrenaline are high affinity agonists at dopamine D4 receptors. Eur J Pharmacol. 319:1997;379-383.
32. Nicholls B., Springham A., Mellanby J. The playground maze: a new method for measuring directed exploration in the rat. J Neurosci Methods. 43:1992;171-180.
33. Noble E.P., Ozkaragoz T.Z., Ritchie T.L., Zhang X., Belin T.R., Sparkes R.S. D2 and D4 dopamine receptor polymorphisms and personality. Am J Med Genet. 81:1998;257-267.
34. Patel S., Freedman S., Chapman K.L., Emms F., Fletcher A.E., Knowles M., Marwood R., McAllister G., Myers J., Patel S., Curtis N., Kulagowski J.J., Leeson P.D., Ridgill M., Graham M., Matheson S., Rathbone D., Watt A.P., Bristow L.J., Rupniak N.M.J., Baskin E., Lynch J.J., Ragan C.I. Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptor. J Pharmacol Exp Ther. 283:1997;636-647.
35. Pedersen W., Clausen S.E., Lavik N.J. Patterns of drug use and sensation-seeking among adolescents in Norway. Acta Psychiatr Scand. 79:1989;386-390.
36. Piazza P.V., Deminiere J.M., Le Moal M., Simon H. Factors that predict individual vulnerability to amphetamine self-administration. Science. 245:1989;1511-1513.
37. Pudovkina O.L., Kawahara Y., de Vries J., Westerink B.H. The release of noradrenaline in the locus coeruleus and prefrontal cortex studied with dual-probe microdialysis. Brain Res. 906:2001;38-45.
38. Rex A., Voigt J.P., Voits M., Fink H. Pharmacological evaluation of a modified open-field test sensitive to anxiolytic drugs. Pharmacol Biochem Behav. 59:1998;677-683.
39. Schlaeger E.J., Schumpp B. Propagation of a mouse myeloma cell line J558L producing human CD4 immunoglobulin G1. J Immunol Methods. 146:1992;111-120.
40. Sheldon A.B. Preference for familiar versus novel stimuli as a function of the familiarity of the environment. J Comp Physiol Psychol. 67:1969;516-521.
41. Teichman M., Barnea Z., Ravav G. Personality and substance use among adolescents: a longitudinal study. Br J Addict. 84:1989;181-190.
42. Tomitaka M., Tomitaka S., Otuka Y., Kim K., Matuki H., Sakamoto K., Tanaka A. Association between novelty seeking and dopamine receptor D4 (DRD4) exon III polymorphism in Japanese subjects. Am J Med Genet. 88:1999;469-471.
43. Van Tol H.H., Wu C.M., Guan H.C., Ohara K., Bunzow J.R., Civelli O., Kennedy J., Seeman P., Niznik H.B., Jovanovic V. Multiple dopamine D4 receptor variants in the human population. Nature. 358:1992;149-152.
44. Wedzony K., Chocyk A., Mackowiak M., Fijal K., Czyrak A. Cortical localization of dopamine D4 receptors in the rat brain-immunocytochemical study. J Physiol Pharmacol. 51:2000;205-221.
45. Welker W.I. 'Free' versus 'forced' exploration of a novel situation by rats. Psychol Rep. 3:1957;95-108.
46. Zhang K., Tarazi F.I., Baldessarini R.J. Role of dopamine D(4) receptors in motor hyperactivity induced by neonatal 6-hydroxydopamine lesions in rats. Neuropsychopharmacology. 25:2001;624-632.
47. Zhang K., Davids E., Tarazi F.I., Baldessarini R.J. Effects of dopamine D4 receptor-selective antagonists on motor hyperactivity in rats with neonatal 6-hydroxydopamine lesions. Psychopharmacology (Berl). 161:2002a;100-106.
48. Zhang K., Tarazi F.I., Davids E., Baldessarini R.J. Plasticity of dopamine D4 receptors in rat forebrain: temporal association with motor hyperactivity following neonatal 6-hydroxydopamine lesioning. Neuropsychopharmacology. 26:2002b;625-633.